Bintrafusp Alfa and Pimasertib for the Treatment of Patients With Brain Metastases
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
H. Lee Moffitt Cancer Center and Research Institute
Pfizer
H. Lee Moffitt Cancer Center and Research Institute
Tempus AI
Vedanta Biosciences, Inc.
Eisai Inc.
Anaveon AG
Incyte Corporation
Incyte Corporation
University of California, San Diego
NRG Oncology
Biogen
Grupo Español Multidisciplinar de Melanoma
ImmunoGenesis
Incyte Corporation
Fred Hutchinson Cancer Center
Altor BioScience
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Pfizer
Eli Lilly and Company
Memorial Sloan Kettering Cancer Center
NextCure, Inc.
Rutgers, The State University of New Jersey
Clinigen, Inc.
The Methodist Hospital Research Institute
Nektar Therapeutics
Nektar Therapeutics
Herlev Hospital
Grupo Español Multidisciplinar de Melanoma
Idera Pharmaceuticals, Inc.
H. Lee Moffitt Cancer Center and Research Institute
Pfizer
M.D. Anderson Cancer Center
Eisai Inc.
M.D. Anderson Cancer Center
National Institutes of Health Clinical Center (CC)
Pfizer
GlaxoSmithKline
Eli Lilly and Company
Merck Sharp & Dohme LLC
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
University of Pittsburgh
National Institutes of Health Clinical Center (CC)
Adaptimmune
Alliance for Clinical Trials in Oncology